RT Journal Article
SR Electronic
T1 Substantial underestimation of SARS-CoV-2 infection in the United States due to incomplete testing and imperfect test accuracy
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.12.20091744
DO 10.1101/2020.05.12.20091744
A1 Wu, Sean L.
A1 Mertens, Andrew
A1 Crider, Yoshika S.
A1 Nguyen, Anna
A1 Pokpongkiat, Nolan N.
A1 Djajadi, Stephanie
A1 Seth, Anmol
A1 Hsiang, Michelle S.
A1 Colford, John M.
A1 Reingold, Art
A1 Arnold, Benjamin F.
A1 Hubbard, Alan
A1 Benjamin-Chung, Jade
YR 2020
UL http://medrxiv.org/content/early/2020/05/18/2020.05.12.20091744.abstract
AB Accurate estimates of the burden of SARS-CoV-2 infection are critical to informing pandemic response. Current confirmed COVID-19 case counts in the U.S. do not capture the total burden of the pandemic because testing has been primarily restricted to individuals with moderate to severe symptoms due to limited test availability. We used a semi-Bayesian method to perform a probabilistic bias analysis on cumulative confirmed COVID-19 counts, incorporating relevant prior knowledge from existing studies about SARS-CoV-2 testing probabilities and diagnostic accuracy parameters while accounting for uncertainty. We estimate 6,275,072 cumulative infections compared to 721,245 confirmed cases (1.9% vs. 0.2% of the population) as of April 18, 2020. Accounting for uncertainty, the number of infections was 3 to 20 times higher than the number of confirmed cases. 86% (simulation interval: 64-99%) of this difference was due to incomplete testing, while 14% (0.3-36%) was due to imperfect test accuracy. Estimates of SARS-CoV-2 infections that transparently account for testing practices and diagnostic accuracy reveal that the pandemic is larger than confirmed case counts suggest.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by FluLab. The funders of the study had no role in the study design, data analysis, data interpretation, or writing of the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data necessary to reproduce the findings of this study have been made publicly available at the GitHub repository https://github.com/jadebc/covid19-infections https://github.com/jadebc/covid19-infections